Are circulating autoantibodies to ABCC3 transporter a potential biomarker for lung cancer?

Journal of Cancer Research and Clinical Oncology

Volumn 138, Issue 10, 2012, Pages 1737-1742

  Liu, Linlin ^a   Liu, Nian ^a   Liu, Baogang ^b   Yang, Yanming ^a   Zhang, Qi ^a   Zhang, Weijing ^a   Yu, Pengyue ^a   Jin, Yonglong ^a   Guo, Jia ^a   Guan, Songlei ^a   Sun, Shilong ^a   Miao, Lining ^a   Wei, Jun ^c  

^a JILIN UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF THE HIGHLANDS AND ISLANDS   (United Kingdom)

Author keywords

ABCC3 transporter; Autoantibody; Biomarkers; Lung cancer; Tumor immunity

Indexed keywords

ABC TRANSPORTER; ATP BINDING CASSETTE TRANSPORTER C3; AUTOANTIBODY; EPITOPE; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; AUTOANTIBODIES; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PROTEIN TRANSPORT; TUMOR MARKERS, BIOLOGICAL;

EID: 84866677533     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1260-9     Document Type: Article

References (22)

1. Abendstein B, Daxenbichler G, Windbichler G, Zeimet AG, Geurts A, Sweep F, Marth C (2000) Predictive value of uPA, PAI-1, HER-2 and VEGF in the serum of ovarian cancer patients. Anticancer Res 20(1B): 569-572
2. Anderson KS, Wong J, Vitonis A, Crum CP, Sluss PM, Labaer J, Cramer D (2010) p53 autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancer. Cancer Epidemiol Biomarkers Prev 19(3):859-868
3. Boyle P, Chapman CJ, Holdenrieder S, Murray A, Robertson C, Wood WC, Maddison P, Healey G, Fairley GH, Barnes AC, Robertson JF (2011) Clinical validation of an autoantibody test for lung cancer. Ann Oncol 22:383-389
4. Calcagno AM, Ambudkar SV (2010) Molecular mechanisms of drug resistance in single-step and multi-step drug-selected cancer cells. Methods Mol Biol 596:77-93
5. Chapman C, Murray A, Chakrabarti J, Thorpe A, Woolston C, Sahin U, Barnes A, Robertson J (2007) Autoantibodies in breast cancer: their use as an aid to early diagnosis. Ann Oncol 18: 868-873
6. Chapman CJ, Thorpe AJ, Murray A, Parsy-Kowalska CB, Allen J, Stafford KM, Chauhan AS, Kite TA, Maddison P, Robertson JF (2011) Immunobiomarkers in small cell lung cancer: potential early cancer signals. Clin Cancer Res 17:1474-1480
7. Gatti L, Cossa G, Beretta GL, Zaffaroni N, Perego P (2011) Novel insights into targeting ATP-binding cassette transporters for antitumor therapy. Curr Med Chem 18:4237-4249
8. Goodell V, Salazar LG, Urban N, Drescher CW, Gray H, Swensen RE, McIntosh MW, Disis ML (2006) Antibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian cancer. J Clin Oncol 24:762-768
9. Järås K, Anderson K (2011) Autoantibodies in cancer: prognostic biomarkers and immune activation. Expert Rev Proteomics 8: 577-589
10. Kobold S, Lütkens T, Cao Y, Bokemeyer C, Atanackovic D (2010) Autoantibodies against tumor-related antigens: incidence and biologic significance. Hum Immunol 71:643-651
11. Lam S, Boyle P, Healey GF, Maddison P, Peek L, Murray A, Chapman CJ, Allen J, Wood WC, Sewell HF, Robertson JF (2011) EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer. Cancer Prev Res (Phila) 4:1126-1134
12. Liu W, Peng B, Lu Y, Xu W, Qian W, Zhang J-Y (2011) Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis. Autoimmun Rev 10:331-335
13. Marzac C, Garrido E, Tang R, Fava F, Hirsch P, De Benedictis C, Corre E, Lapusan S, Lallemand JY, Marie JP, Jacquet E, Legrand O (2011) ATP Binding Cassette transporters associated with chemoresistance: transcriptional profiling in extreme cohorts and their prognostic impact in a cohort of 281 acute myeloid leukemia patients. Haematologica 96:1293-1301
14. Mayerhofer K, Tempfer C, Kucera E, Hefler L, Zeisler H, Kainz C, Zeillinger R, Sliutz G (1999) Humoral p53 antibody response is a prognostic parameter in ovarian cancer. Anticancer Res 19 (1B): 875-878
15. Murray A, Chapman CJ, Healey G, Peek LJ, Parsons G, Baldwin D, Barnes A, Sewell HF, Fritsche HA, Robertson JF (2010) Technical validation of an autoantibody test for lung cancer. Ann Oncol 21:1687-1693
16. Piura E, Piura B (2010) Autoantibodies to tumor-associated antigens in breast carcinoma. J Oncol 2010: 264926 (Epub)
17. Piura E, Piura B (2011) Autoantibodies to tailor-made panels of tumor-associated antigens in breast carcinoma. J Oncol 2011: 982425 (Epub)
18. Reuschenbach M, von Knebel Doeberitz M, Wentzensen N (2009) A systematic review of humoral immune responses against tumor antigens. Cancer Immunol Immunother 58:1535-1544
19. Söllner J, Heinzel A, Summer G, Fechete R, Stipkovits L, Szathmary S, Mayer B (2010) Concept and application of a computational vaccinology workflow. Immunome Res 6(Suppl 2):S7
20. Tan HT, Low J, Lim SG, Chung MC (2009) Serum autoantibodies as biomarkers for early cancer detection. FEBS J 276:6880-6904
21. Wang P, Sidney J, Kim Y, Sette A, Lund O, Nielsen M, Peters B (2010) Peptide binding predictions for HLA DR, DP and DQ molecules. BMC Bioinf 11: 568 (Epub)
22. Zhong L, Coe SP, Stromberg AJ, Khattar NH, Jett JR, Hirschowitz EA (2006) Profiling tumor-associated antibodies for early detection of non-small cell lung cancer. J Thorac Oncol 1:513-519